Avid Bioservices Inc (CDMO)

[entdoc]

good posts this a.m. docroc,senrex,vol,et.al. Most important, we have Bavi in PIII. That's huge. We need to stay focused on that. Does anyone know if the front-line trial was run by the same co. that screwed up second-line? There are those here who understand the basic science of anti-phospholipid therapy; there are those here who have witnessed the awesome lower animal trials. There are also those here who have seen the difficulties of transferring those observations safely and with efficacy to humans. Safety is paramount, and it looks like we have that. With well established large cancers we cannot send in a missile to cruise the area and recruit immune-fighter into the area. For large tumors we also need a missile with carrying capabilities, of being heavily armed. PPHM has that too. This has all the makings of a $4-5 sell-out for a $50-100 downstream blockbuster. Things are looking better for a BP with deep pockets than for retail stockholders. I'm still in.